Biogena Group Invest AGWBO:BIO +2.67%65 Current Ratio is 26.31 as of Jan. 2026, which is 158% above its 10-year median of 10.18. GuruFocus rates WBO:BIO with a GF Score™ of 65/100 and a GF Value™ of €3.46 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,986 Consumer Packaged Goods companies, Biogena Group Invest AG ranks better than 98.59% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Biogena Group Invest AG's current ratio for the quarter that ended in Jan. 2026 was 26.31.
Biogena Group Invest AG has a current ratio of 26.31. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Biogena Group Invest AG's Current Ratio or its related term are showing as below:
WBO:BIO'
s Current Ratio Range Over the Past 10 Years
Min: 3.78 Med: 10.18 Max: 26.31
Current: 26.31
During the past 7 years, Biogena Group Invest AG's highest Current Ratio was 26.31. The lowest was 3.78. And the median was 10.18.
WBO:BIO's Current Ratio is ranked better than 98.59% of 1986
companies
in the Consumer Packaged Goods industry
Industry Median: 1.73
vs WBO:BIO: 26.31
Biogena Group Invest AG (WBO:BIO) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Biogena Group Invest AG Current Ratio Related Terms
Biogena Group Invest AG Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:BIO vs KHC, GIS, HRL: Current Ratio Comparison
For the Packaged Foods subindustry, Biogena Group Invest AG's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biogena Group Invest AG Current Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Biogena Group Invest AG's Current Ratio distribution charts can be found below:
* The bar in red indicates where Biogena Group Invest AG's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biogena Group Invest AG (WBO:BIO) has a Current Ratio of 26.31 as of Jan. 2026. This is 158% above median its historical median of 10.18. Over the past decade, Biogena Group Invest AG's Current Ratio has ranged from 3.78 to 26.31. According to the industry distribution chart, Biogena Group Invest AG ranks #28 out of 1986 companies in the Consumer Packaged Goods industry, placing it in the top 1.4%.
Is Biogena Group Invest AG's Current Ratio too high?
Biogena Group Invest AG's current Current Ratio of 26.31 is 158% above median its 10-year median of 10.18. Over the past 10 years, this metric has ranged from a low of 3.78 to a high of 26.31. The Consumer Packaged Goods industry median Current Ratio is 1.73. Biogena Group Invest AG's value of 26.31 is 1420.8% above this industry median. Based on the distribution chart, Biogena Group Invest AG ranks #28 out of 1986 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Biogena Group Invest AG has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biogena Group Invest AG's Current Ratio compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Biogena Group Invest AG ranks #28 out of 1986 companies for Current Ratio. This places Biogena Group Invest AG in the top 1% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.73. Biogena Group Invest AG's value of 26.31 is 1420.8% above this benchmark. Historically, Biogena Group Invest AG's own Current Ratio has ranged from 3.78 to 26.31 over the past decade. While the company's 10-year median is 10.18 vs. the industry median of 1.73, Biogena Group Invest AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Consumer Packaged Goods company?
The median Current Ratio among Consumer Packaged Goods companies is 1.73, based on 1,986 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biogena Group Invest AG's current Current Ratio of 26.31 is 1420.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Consumer Packaged Goods industry, the median Current Ratio is 1.73 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biogena Group Invest AG's current Current Ratio is 26.31, which is 158% above median its own 10-year median of 10.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biogena Group Invest AG stock overvalued right now?
Based on GuruFocus' analysis, Biogena Group Invest AG (WBO:BIO) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.46, compared to a current price of €4.62 — trading 33.5% above its estimated fair value. The current Current Ratio is 26.31, which is 158% above median its 10-year median of 10.18 and 1420.8% above the Consumer Packaged Goods industry median of 1.73. Biogena Group Invest AG's overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Biogena Group Invest AG (WBO:BIO), the current Current Ratio is 26.31 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?
Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued.
The current stock price of €4.62 is trading 33.5% above its estimated GF Value™ of €3.46.
GuruFocus considers Biogena Group Invest AG to be Significantly Overvalued.
Key valuation signals for WBO:BIO:
Current Ratio: 26.31 (158% above median its 10-year median of 10.18)
GF Value™: €3.46 vs. price of €4.62 (33.5% above fair value)
Industry Position: 1420.8% above the Consumer Packaged Goods median (#28 of 1986)
No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
65GF Score
Get the complete analysis for WBO:BIO
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:BIO has been successfully added to your 